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Eczema Consensus
Schmitt and colleagues 
performed an international, 
multiperspective, three-stage 
Delphi consensus project to 
develop core sets of outcome 
domains for eczema in order to 
facilitate controlled trials and 
clinical practice recordkeeping. 
In this study, 46 individuals, 
including consumers, clinical 
experts, journal editors, and 
regulatory agencies, came 
together to recommend 
assessment of symptoms, clinical 
signs, and long-term control of 
flares in eczema trials. Inclusion 
of these core outcomes in future 
trials will allow greater clinical 
interpretation and enable 
meta-analyses. This group also 
supported regular monitoring 
of symptoms in daily clinical 
care of eczema patients for 
recordkeeping. See page 623
Risks of Being Elderly
In a large, prospective 
multicenter hospital-based 
case–control study in 11 
dermatology departments 
in France, Bastuji-Garin and 
colleagues examined risk 
factors for bullous pemphigoid 
(BP), an autoimmune blistering 
disease that mainly affects 
the elderly. Independent risk 
factors for BP were dementia, 
Parkinson’s disease, unipolar 
or bipolar disorder, bedridden 
condition, and chronic 
intake of spironolactone 
or psycholeptic agents. In 
addition to offering information 
relevant to the management 
of BP patients, these studies 
support further investigations 
into the link between BP and 
neurological disorders and, 
in particular, between BP and 
neurodegenerative disorders. 
See page 637
Special Delivery
Johnson and colleagues 
engin eered the base excision 
repair pathway pyrimidine 
dimer-specific DNA glyco-
sylase from Chlorella virus 
linked with a nuclear 
translocation signal and the 
membrane-permeabilization 
peptide (transcriptional 
trans activator, or TAT). This 
modified enzyme was deliv-
ered not only to cultured 
human keratinocytes and 
fibroblasts but also across 
the stratum corneum to 
basal keratino cytes in a 
stratified human skin model. 
Most importantly, this 
enzyme increased the rate 
of initiation of cyclo butane 
pyrimidine dimer repair in 
repair-proficient skin follow-
ing UVB exposure. These 
results suggest that this engi-
neered enzyme may prove 
useful for prevention of skin 
cancer in highly susceptible nucleotide excision repair–deficient xeroderma 
pigmentosum patients or other high-risk patients. See page 753
Women versus Men
Although numerous studies 
have found gender to be an 
independent prognostic factor 
for melanoma, with females 
exhibiting longer survival than 
males, the effects of gender 
on survival and progression 
patterns were not known. An 
examination by Joosse and 
colleagues of 11,734 patients 
from the Munich Cancer 
Registry revealed that females 
have a significantly lower risk 
of lymph node and distant 
metastases as compared with 
males, even after adjustment for relevant prognostic factors. These results were 
observed across different melanoma stages. Because of a lower propensity for 
localized melanomas to metastasize in women, women exhibited a better sur-
vival rate. See page 719
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